PharmaCyte Biotech PMCB Cash Flow Statement (2010-2026)

NASDAQ PMCB
$0.40 -0.01 (-1.63%)
As of: Oct 1, 2026 · 3:59 PM EDT
Reported Financials

PharmaCyte Biotech Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jul 2026

PharmaCyte Biotech reported cash from operations of -$0.78M and free cash flow of -$0.78M for the quarter ended Jul 2026, up 60.8% year over year. This cash flow statement covers 65 quarters of results from Jul 2010 through Jul 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Jan2012 Apr2012 Jul2012 Oct2012 Jan2013 Apr2013 Jul2013 Oct2013 Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Apr2019 Jul2019 Oct2019 Jan2020 Apr2020 Jul2020 Oct2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026 Jul2026
Operating Activities
Net Income
-0.98M-0.81M-1.42M-1.54M-1.88M-0.92M-0.18M-1.20M-0.52M-0.99M-2.42M-0.72M-0.72M-0.70M-0.81M-0.63M-1.17M-1.89M-2.43M-0.84M
Share-based Compensation
0.00M0.00M0.00M0.00M0.00M667.000.91M-0.91M0.67M0.22M0.12M-0.34M0.06M0.06M0.77M
Cash from Operations
-1.39M-0.30M-1.19M-1.08M-1.88M-0.54M-0.29M0.34M-1.98M-0.18M-0.33M-0.37M-1.05M-0.51M-1.04M-1.99M-0.98M-0.79M-1.39M-0.78M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
Change in Working Capital
Change in Receivables
Change in Inventory
Change in Account Payables
-0.01M-0.06M0.11M0.35M0.30M-0.58M-0.32M0.59M-0.59M0.36M-0.09M0.16M-0.21M0.14M-0.09M0.07M0.47M0.18M-0.84M0.12M
Change in Accured Expenses
-0.50M0.49M0.03M0.03M-0.08M-0.07M0.08M0.02M0.27M-0.25M0.14M-0.06M0.01M1.001.36M-1.01M-0.07M-0.54M0.08M-0.18M
Other Working Capital Changes
-0.08M-0.07M-0.08M-0.07M0.23M-0.08M-0.07M-0.02M0.23M-0.03M-0.04M-0.02M0.25M-0.29M0.02M0.01M0.26M-0.34M0.32M0.12M
Investing Activities
Change in Intangibles
Acquisitions
Cash from Investing Activities
-5.00M-7.00M-3.00M5.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
0.05M
Change in Capital Stock
Net Preferred Shares Issued and Repurchased
35.00M-1.35M
Net Equity Issued and Repurchased
55.69M31.67M880.0070.00-0.09M
Misc.
Cash from Financing Activities
87.36M-0.05M-2.09M-3.39M-3.78M-4.31M6.28M0.75M-7.04M-10.70M-10.17M-10.74M-3.95M-0.17M6.21M0.54M-0.17M-0.08M
Exchange Rate Effect
0.00M-210.000.00M0.00M-720.00-0.00M-0.01M451.00-0.00M0.00M-438.00183.0061.00-0.00M617.00123.00-381.000.00M744.00-615.00
Change in Cash
85.98M-0.30M-1.24M-3.17M-5.27M-4.32M-4.60M6.62M-1.24M-12.21M-11.03M-17.54M-11.80M-4.46M-1.21M-1.99M2.23M4.76M-1.56M-0.86M
Free Cash Flow
-1.39M-0.30M-1.19M-1.08M-1.88M-0.54M-0.29M0.34M-1.98M-0.18M-0.33M-0.37M-1.05M-0.51M-1.04M-1.99M-0.98M-0.79M-1.39M-0.78M
Net Cash Flow
85.98M-0.30M-1.24M-3.17M-5.26M-4.32M-4.60M6.62M-1.24M-12.22M-11.03M-17.55M-11.80M-4.46M-1.21M-1.99M2.23M4.76M-1.56M-0.86M

PharmaCyte Biotech Cash Flow Statement API

Pull PharmaCyte Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PMCB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY